AbbVie Inc. — Director's Dealing 2017

Feb 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REATA PHARMACEUTICALS INC (RETA)
CIK: 0001358762
Period of Report: 2017-02-02

Reporting Person: AbbVie Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-02	Class A Common Stock	C	1505241	—	Acquired	1640473	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-02	Class B Common Stock	$	C	1505241	Disposed		Class A Common Stock (1505241)	Direct

Footnotes

F1: The Class B common stock is convertible in Class A common stock on a one-for-one basis at the holder's election at any time after November 22, 2016. The conversion right of the Class B common stock has no expiration date.